Premium
Exubera: first inhaled insulin for the management of diabetes
Author(s) -
Barnett Anthony
Publication year - 2007
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.39
Subject(s) - medicine , diabetes mellitus , type 2 diabetes , insulin , interface (matter) , diabetes management , intensive care medicine , endocrinology , engineering , pulmonary surfactant , gibbs isotherm , chemical engineering
Exubera is a dry‐powder inhaled formulation of insulin that has now gained licence approval in the UK for use in patients with both type 1 and type 2 diabetes. Here, Professor Barnett discusses the properties of this novel therapeutic option and its potential role in the current and future management of diabetes. Copyright © 2007 Wiley Interface Ltd
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom